Is thrombolytic therapy effective for pulmonary embolism?

Area of Science:

• Cardiology
• Pulmonology
• Emergency Medicine

Background:

• Pulmonary embolism (PE) is a serious condition with high morbidity and mortality.
• Right-sided heart failure and recurrent PE are primary causes of early death post-embolism.
• Thrombolysis offers potential life-saving benefits but carries significant risks.

Purpose of the Study:

• To review the indications and effectiveness of thrombolysis for pulmonary embolism.
• To evaluate the risks and benefits of thrombolytic therapy compared to standard anticoagulation.
• To clarify the controversial indications for thrombolysis in PE management.

Main Methods:

• Literature review of studies on thrombolysis in pulmonary embolism.
• Analysis of evidence regarding thrombolysis efficacy for mortality, recurrent PE, and chronic complications.
• Examination of reported complications, particularly bleeding events.

Main Results:

• Massive PE with hypotension is the only absolute indication for thrombolysis.
• Potential indications like right heart dysfunction and recurrent PE lack supporting evidence for improved outcomes over anticoagulation.
• Bleeding is the most frequent and potentially fatal complication of thrombolysis.

Conclusions:

• Thrombolytic therapy for PE should be used cautiously due to significant bleeding risks.
• Current evidence does not support thrombolysis over anticoagulation for preventing mortality or chronic PE complications.
• Further research is needed to define clear benefits and risks for specific PE patient subgroups.